{"id":3227,"date":"2026-08-26T22:45:17","date_gmt":"2026-08-26T22:45:17","guid":{"rendered":"https:\/\/valutednews.com\/?p=3227"},"modified":"2026-08-26T22:45:17","modified_gmt":"2026-08-26T22:45:17","slug":"gsk-shingles-dolly-parton-cardio-heatlh-readout-newsletter","status":"publish","type":"post","link":"https:\/\/valutednews.com\/?p=3227","title":{"rendered":"GSK, shingles, Dolly Parton, cardio heatlh: Readout Newsletter"},"content":{"rendered":"
<\/div>

<\/p>\n

\n

Elaine\u2019s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter<\/a>, and co-hosts STAT\u2019s weekly biotech podcast, The Readout Loud<\/a>. You can reach Elaine on Signal at elaineywchen.70.<\/p>\n<\/div>\n

\n

Want to stay on top of the science and politics driving biotech today?\u00a0Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n

Good morning. We are thinking of Dolly Parton, who made a lasting impact not only in music and culture, but also in science. During the Covid-19 pandemic,\u00a0she donated $1 million<\/a> to Vanderbilt University Medical Center to help speed the development of Moderna\u2019s\u00a0vaccine.pharma\n<\/p>\n

Key data on a new class of cardio drugs are coming<\/h2>\n

Several large pharma companies are betting that targeting a particle called lipoprotein(a) will be the next big advance in cardiovascular medicine. We\u2019ll soon find out how well\u00a0the approach\u00a0works.<\/p>\n

\n
\n

STAT+ Exclusive Story<\/p>\n

Already have an account? Log in<\/a><\/p>\n<\/p><\/div>\n

\t\t\t\"STAT+\"\/<\/p>\n

\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\"STAT+\"\/
\n\t\t\t\t\t<\/a>
\n\t\t\t\t<\/span><\/p>\n

This article is exclusive to STAT+ subscribers<\/h2>\n

Unlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/h3>\n

Already have an account? Log in<\/a><\/p>\n

\n
\n\t\t\t\t\t\t